Advance in studies on effect of paeoniflorin on nervous system

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 3, 2013, Pages 297-301

  Hu, Zeng Yao ^a   Xu, Lan ^a   Yan, Rong ^a   Huang, Yan ^a   Liu, Gang ^a   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Adenosine A1 receptor; Albiflorin; Cerebral ischemia; Neurodegenerative disorders; Paeoniflorin

Indexed keywords

ADENOSINE A1 RECEPTOR; CALCIUM CHANNEL; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OPIATE RECEPTOR; PAEONIFLORIN;

BRAIN ISCHEMIA; BRAIN PROTECTION; DEMENTIA; DRUG ACTIVITY; DRUG EFFECT; LEARNING; MEMORY; NONHUMAN; PAEONIA; PARKINSON DISEASE; REVIEW;

ANIMALS; BENZOATES; BRIDGED COMPOUNDS; CALCIUM CHANNELS; GLUCOSIDES; LEARNING; MEMORY; NERVOUS SYSTEM; NF-KAPPA B; RECEPTOR, ADENOSINE A1;

EID: 84877041419     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20130301     Document Type: Review

References (28)

1. Ohta H, Ni J W, Matsumoto K, et al. Peony and its major constituent, paeoniflorin, improve radial maze performance impaired by scopolamine in rats [J]. Pharmacol Biochem Behav, 1993, 45 (3): 719.
2. 2006, 22(1): 23.
3. Zhong S Z, Ge Q H, Li Q, et al. Peoniflorin attentuates Abeta (1-42) -mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats [J]. J Neurol Sci, 2009, 280(1/2): 71.
4. Hu Z Y, Liu G, Yuan H, et al. Danggui-Shaoyao-San and its active fraction JD-30 improve Abeta-induced spatial recognition deficits in mice [J]. J Ethnopharmacol, 2010, 128(2): 365.
5. Hu Z Y, Liu G, Cheng X R, et al. JD-30, an active fraction extracted from Danggui-Shaoyao-San, decreases beta-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice [J]. Exp Gerontol, 2012, 47(1): 14.
6. Abdel-Hafez A A, Meselhy M R, Nakamura N, et al. Effects of paeoniflorin derivatives on scopolamine-induced amnesia using a passive avoidance task in mice: structure-activity relationship [J]. Biol Pharm Bull, 1998, 21 (11): 1174.
7. Liu H Q, Zhang W Y, Luo X T, et al. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine Al receptor [J]. Br J Pharmacol, 2006, 148(3): 314.
8. Liu D Z, Zhu J, Jin D Z, et al. Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease [J]. J Ethnopharmacol, 2007, 112(2): 327.
9. Liu J, Jin D Z, Xiao L, et al. Paeoniflorin attenuates chronic cerebral hypoperfusion-induced learning dysfunction and brain damage in rats [J]. Brain Res, 2006, 1089(1): 162.
10. Liu D Z, Xie K Q, Ji X Q, et al. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine Al receptor in a manner different from its classical agonists [J]. Br J Pharmacol, 2005, 146(4): 604.
11. Tang N Y, Liu C H, Hsieh C T, et al. The anti-inflammatory effect of paeoniflorin on cerebral infarction induced by ischemia-reperfusion injury in Sprague-Dawley rats [J]. Am J Chin Med, 2010, 38(1): 51.
12. Chen D M, Xiao L, Cai X, et al. Involvement of multitargets in paeoniflorin-induced preconditioning [J]. J Pharmacol Exp Ther, 2006, 319(1): 165.
13. Xiao L, Wang Y Z, Liu J, et al. Effects of paeoniflorin on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of transient middle cerebral artery occlusion in rats [J]. Life Sci, 2005, 78(4): 413.
14. Yu H Y, Liu M G, Liu D N, et al. Antinociceptive effects of systemic paeoniflorin on bee venom-induced various 'phenotypes' of nociception and hypersensitivity [J]. Pharmacol Biochem Behav, 2007, 88(2): 131.
15. Yu H Y, Mu D G, Chen J, et al. Suppressive effects of intrathecal paeoniflorin on bee venom-induced pain-related behaviors and spinal neuronal activation [J]. Pharmacology, 2011, 88 (3/4): 159.
16. Tsai H Y, Lin Y T, Tsai C H, et al. Effects of paeoniflorin on the formalin-induced nociceptive behaviour in mice [J]. J Ethnopharmacol, 2001, 75(2/3): 267.
17. Liu D Z, Zhao F L, Liu J, et al. Potentiation of adenosine Al receptor agonist CPA-induced antinociception by paeoniflorin in mice [J]. Biol Pharm Bull, 2006, 29(8): 1630.
18. Tabata K, Matsumoto K, Watanabe H. Paeoniflorin, a major constituent of peony root, reverses muscarinic M1-receptor antagonist-induced suppression of long-term potentiation in the rat hipp-ocampal slice [J]. Jpn J Pharmacol, 2000, 83 (1): 25.
19. 2012, 28 (3): 311.
20. Ohta H, Matsumoto K, Watanabe H, et al. Involvement of alpha 1-but not alpha 2-adrenergic systems in the antagonizing effect of paeoniflorin on scopolamine-induced deficit in radial maze performance in rats [J]. Jpn J Pharmacol, 1993, 62(2): 199.
21. Ohta H, Matsumoto K, Watanabe H, et al. Involvement of beta-adrenergic systems in the antagonizing effect of paeoniflorin on the scopolamine-induced deficit in radial maze performance in rats [J]. Jpn J Pharmacol, 1993, 62(4): 345.
22. Tabata K, Matsumoto K, Murakami Y, et al. Ameliorative effects of paeoniflorin, a major constituent of peony root, on adenosine Al receptor-mediated impairment of passive avoidance performance and long-term potentiation in the hippocampus [J]. Biol Pharm Bull, 2001, 24(5): 496.
23. 2+ current by paeoniflorin, a major constituent of peony root, in NG108-15 neuronal cells [J]. Eur J Pharmacol, 2005, 523 (1/3): 16.
24. Zhang G Q, Hao X M, Chen S Z, et al. Blockade of paeoniflorin on sodium current in mouse hippocampal CA1 neurons [J]. Acta Pharmacol Sin, 2003, 24 (12): 1248.
25. + and acidic damage via autophagic pathway [J]. J Ethnopharmacol, 2010, 131 (1): 122.
26. Sun X, Cao Y B, Hu L F, et al. ASICs mediate the modulatory effect by paeoniflorin on alpha-synuclein autophagic degradation [J]. Brain Res, 2011, 1396: 77.
27. 2010, 35(18): 2457.
28. 2011, 2(6): 35.